Tianqing Ganping, also known as diammonium glycyrrhizinate enteric-coated capsules, can stop taking the drug for two months need to be determined according to the condition. If the patient’s symptoms improve or serious adverse reactions can be discontinued; if the patient’s condition does not improve, and no serious adverse reactions are generally not recommended to stop. Diammonium glycyrrhizinate enteric capsule is mainly used for the treatment of chronic hepatitis B accompanied by elevated ghrelin aminotransferase, and its treatment is aimed at inhibiting or eliminating hepatitis viruses, reducing hepatocellular inflammation and necrosis and hepatic fibrosis, and slowing down and stopping the progression of the disease. It also reduces and prevents the occurrence of complications such as cirrhosis. If the above conditions are basically controlled after two months of administration, the condition is delayed and the liver function test is basically normal, and no complications occur, the drug can be discontinued or the dosage can be reduced according to the doctor’s instructions. If there are serious adverse reactions such as hypertension, sodium retention, hypokalemia, etc. after taking the drug, the drug should be discontinued according to the doctor’s advice. On the contrary, if the patient’s condition is still not controlled or relieved after two months of taking the drug. And the body does not appear adverse reactions is generally not recommended to stop the drug, it is recommended that patients continue to take the drug treatment. To summarize, diammonium glycyrrhizinate enteric capsules eaten for two months can stop the drug needs to be depending on the situation. It is recommended that patients seek medical advice before stopping the drug, the specific whether to stop the drug should be informed by the doctor shall prevail.